Variant Creutzfeldt-Jakob disease: A summary of current scientific knowledge in relation to public health

CMAJ. Canadian Medical Association Journal

Volumn 165, Issue 1, 2001, Pages 51-58

  Coulthart, M B ^a   Cashman, N R ^a  

^a Canadian Science Centre for Human and Animal Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HUMAN; NONHUMAN; POLICY; REVIEW; RISK MANAGEMENT;

EID: 0034915421     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Über eine eigenartige herdförmige erkrankung des zentral-nervensystems
2. 1755 And all that: A historical primer of transmissible spongiform encephalopathy
3. A prion primer
4. Prions
5. The risk of blood-borne Creutzfeldt-Jakob disease
6. Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: Systematic review of case-control studies
7. Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering
8. Virus-like sensitivity of the scrapie agent to heat inactivation
9. Scrapie infectious agent is virus-like in size and susceptibility to inactivation
10. Experimental transmission of a kuru-like syndrome to chimpanzees
11. Iatrogenic Creutzfeldt-Jakob disease at the millennium
12. Creutzfeldt-Jakob disease in a husband and wife
13. Novel proteinaceous infectious particles cause scrapie
14. The scrapie agent: "A virus by any other name"
15. Human TSE disease - Viral or protein only?
16. Prion protein and the transmissible spongiform encephalopathies
17. BSE and prions: Uncertainties about the agent
18. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: A systematic analysis of predisposing mutations and allelic variation in the PRNP gene
19. A novel progressive spongiform encephalopathy in cattle
20. Solvent extraction as an adjunct to rendering: The effect on BSE and scrapie agents of hot solvents followed by dry heat and steam
21. On the origins of BSE
22. Bovine spongiform encephalopathy: Epidemiological studies
23. The epidemiology of bovine spongiform encephalopathy
24. Transmission dynamics and epidemiology of BSE in British cattle
25. Species-barrier-independent prion replication in apparently resistant species
26. A new variant of Creutzfeldt-Jakob disease in the UK
27. New variant Creutzfeldt-Jakob disease: Neurological features and diagnostic tests
28. New variant Creutzfeldt-Jakob disease: Psychiatric features
29. Diagnosis of new variant Creutzfeldt-Jakob disease
30. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease
31. Laboratory diagnosis of variant Creutzfeldt-Jakob disease
32. AIDS as a zoonosis: Scientific and public health implications
33. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man
34. MRI and the second French case of vCJD
35. Autoantibodies to brain components and antibodies to Acinetobacter calcoaceticus are present in bovine spongiform encephalopathy
36. The UK epidemic of BSE: Slow virus or chronic pesticide-initiated modification of the prion protein?
37. Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant cofactors Cu, Se, Fe, Zn: Does a foreign cation substitution at prion protein's Cu domain initiate TSE?
38. Naturally occurring scrapie-like encephalopathy in five domestic cats
39. Sub-acute, transmissible spongiform encephalopathies: Current concepts and future needs
40. Spontaneous spongiform encephalopathy in a young adult rhesus monkey
41. Prion immunoreactivity in brain, tonsil, gastrointestinal epithelial cells, and blood and lymph vessels in lemurian zoo primates with spongiform encephalopathy
42. Natural and experimental oral infection of nunhuman primates by bovine spongiform encephalopathy agents
43. Oral infection by the bovine spongiform encephalopathy prion
44. Bovine spongiform encephalopathy: Case-control studies of calf feeding practices and meat and bone meal inclusion in proprietary concentrates
45. The neuropathology of experimental bovine spongiform encephalopathy in the pig
46. Transmission of bovine spongiform encephalopathy to sheep and goats
47. Experimental transmission of BSE and scrapie to the common marmoset
48. Transmission to mice, sheep and goats and bioassay of bovine tissues
49. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): An update
50. Limited detection of sternal bone marrow infectivity in the clinical phase of experimental bovine spongiform encephalopathy (BSE)
51. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent
52. Molecular analysis of prion strain variation and aetiology of 'new variant' CJD
53. The same prion strain causes vCJD and BSE
54. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy
55. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans
56. Prion immunore-activity in appendix before clinical onset of variant Creutzfeldt-Jakob disease
57. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy
58. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
59. Prion protein expression in human leukocyte differentiation
60. Transmission of BSE by blood transfusion in sheep
61. BSE and transmission through blood
62. Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain
63. Estimation of the number of people incubating variant CJD
64. Predicted vCJD mortality in Great Britain
65. Incidence of variant Creutzfeldt-Jakob disease in the UK
66. Molecular genetics of human prion diseases in Germany
67. Variant Creutzfeldt-Jakob disease
68. Phenotype-genotype studies in kuru: Implications for new variant Creutzfeldt-Jakob disease
69. Retrospective study of prion-protein accumulation in tonsil and appendix tissues
70. Assessment of the prevalence of vCJD through testing tonsils and appendices for abnormal prion protein
71. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy
72. Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components
73. Future uncertain for reliable vCJD screening tests